Abstract
Polyendocrine metabolic ovarian syndrome (PMOS; formerly polycystic ovary syndrome [PCOS]) is a heterogeneous endocrine and metabolic disorder involving reproductive, metabolic, and neuroendocrine abnormalities. The kisspeptin/KISS1R system is a major regulator of gonadotropin-releasing hormone (GnRH) secretion and may contribute to neuroendocrine alterations in PMOS. This systematic review will evaluate relationships between kisspeptin/KISS1R-related measures and neuroendocrine, hormonal, and reproductive features in women with PMOS, including GnRH–gonadotropin activity, sex-steroid profiles, and reproductive manifestations. The potential influence of age, adiposity, insulin resistance, and PMOS phenotype will also be examined. MEDLINE/PubMed, Scopus, Embase, CENTRAL, ClinicalTrials.gov, and the Virtual Health Library will be searched, complemented by grey literature and citation tracking. Eligible human observational and interventional studies will be independently screened and assessed by two reviewers. Data will undergo structured qualitative synthesis, with quantitative synthesis performed when sufficient clinical and methodological comparability exists. By integrating kisspeptin/KISS1R-related measures with downstream features of PMOS, this review aims to clarify the potential functional significance of this signaling system and identify sources of heterogeneity and evidence gaps.